Repositori institucional URV
Español Català English

TÍTOL:

Effect of low glycaemic index or load dietary patterns on glycaemic control and cardiometabolic risk factors in diabetes: systematic review and meta-analysis of randomised controlled trials - imarina:9226186

Autor/s de la URV:Salas Salvadó, Jorge
Autor segons l'article:Chiavaroli, Laura; Lee, Danielle; Ahmed, Amna; Cheung, Annette; Khan, Tauseef A; Mejia, Sonia Blanco; Mirrahimi, Arash; Jenkins, David J A; Livesey, Geoffrey; Wolever, Thomas M S; Rahelic, Dario; Kahleova, Hana; Salas-Salvado, Jordi; Kendall, Cyril W C; Sievenpiper, John L
Adreça de correu electrònic de l'autor:jordi.salas@urv.cat
jordi.salas@urv.cat
Identificador de l'autor:0000-0003-2700-7459
0000-0003-2700-7459
Any de publicació de la revista:2021-08-05
Tipus de publicació:Journal Publications
Referència de l'ítem segons les normes APA:Chiavaroli, Laura; Lee, Danielle; Ahmed, Amna; Cheung, Annette; Khan, Tauseef A; Mejia, Sonia Blanco; Mirrahimi, Arash; Jenkins, David J A; Livesey, G (2021). Effect of low glycaemic index or load dietary patterns on glycaemic control and cardiometabolic risk factors in diabetes: systematic review and meta-analysis of randomised controlled trials. BMJ-British Medical Journal, 374(), n1651-. DOI: 10.1136/bmj.n1651
Referència a l'article segons font original:BMJ-British Medical Journal. 374 n1651-
Resum:OBJECTIVE To inform the update of the European Association for the Study of Diabetes clinical practice guidelines for nutrition therapy. DESIGN Systematic review and meta-analysis of randomised controlled trials. DATA SOURCES Medline, Embase, and the Cochrane Library searched up to 13 May 2021. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Randomised controlled trials of three or more weeks investigating the effect of diets with low glycaemic index (GI)/glycaemic load (GL) in diabetes. OUTCOME AND MEASURES The primary outcome was glycated haemoglobin (HbA1c). Secondary outcomes included other markers of glycaemic control (fasting glucose, fasting insulin); blood lipids (low density lipoprotein cholesterol (LDL-C), high density lipoprotein cholesterol (HDL-C), non-HDL-C, apo B, triglycerides); adiposity (body weight, BMI, waist circumference), blood pressure (systolic blood pressure (SBP) and diastolic blood pressure (DBP)), and inflammation (C reactive protein (CRP)). DATA EXTRACTION AND SYNTHESIS Two independent reviewers extracted data and assessed risk of bias. Data were pooled by random effects models. GRADE (grading of recommendations assessment, development, and evaluation) was used to assess the certainty of evidence. RESULTS 29 trial comparisons were identified in 1617 participants with type 1 and 2 diabetes who were predominantly middle aged, overweight, or obese with moderately controlled type 2 diabetes treated by hyperglycaemia drugs or insulin. Low GI/GL dietary patterns reduced HbA1c in comparison with higher GI/GL control diets (mean difference & minus;0.31% (95% confidence interval & minus;0.42 to & minus;0.19%), P < 0.001; substantial heterogeneity, I2=75%, P < 0.001). Reductions occurred also in fasting glucose, LDL-C, non-HDL-C, apo B, triglycerides, body weight, BMI, and CRP (P < 0.05), but not blood insulin, HDL-C, waist circumference, or blood pressure. A positive dose response gradient was seen for the difference in GL and HbA1c and for absolute dietary GI and SBP (P < 0.05). The certainty of evidence was high for the reduction in HbA1cand moderate for most secondary outcomes, with downgrades due mainly to imprecision. CONCLUSIONS This synthesis suggests that low GI/GL dietary patterns result in small important improvements in established targets of glycaemic control, blood lipids, adiposity, and inflammation beyond concurrent treatment with hyperglycaemia drugs or insulin, predominantly in adults with moderately controlled type 1 and type 2 diabetes. The available evidence provides a good indication of the likely benefit in this population. STUDY REGISTRATION ClinicalTrials.gov NCT04045938.Superscript/Subscript Available
DOI de l'article:10.1136/bmj.n1651
Enllaç font original:https://www.bmj.com/content/374/bmj.n1651
Versió de l'article dipositat:info:eu-repo/semantics/publishedVersion
Accès a la llicència d'ús:https://creativecommons.org/licenses/by/3.0/es/
Departament:Bioquímica i Biotecnologia
URL Document de llicència:https://repositori.urv.cat/ca/proteccio-de-dades/
Àrees temàtiques:Medicine, general & internal
Ciencias sociales
Ciencias humanas
Biotecnología
Paraules clau:Waist circumference
Type-2
Triacylglycerol blood level
Triacylglycerol
Treatment response
Treatment outcome
Systolic blood pressure
Systematic review
Risk algorithm
Review
Randomized controlled trial (topic)
Publication bias
Practice guideline
Patient identification
Outcome assessment
Obesity
Nutrition therapy
Non insulin dependent diabetes mellitus
Mexican-style diet
Metabolic control
Meta analysis
Low density lipoprotein cholesterol level
Low density lipoprotein cholesterol
Lipid profile
Insulin dependent diabetes mellitus
Insulin
Inflammation
Improves dietary
Impaired glucose-tolerance
Humans
Human
High density lipoprotein cholesterol level
High density lipoprotein cholesterol
Hemoglobin a1c
Grade approach
Glycemic load
Glycemic index
Glycemic control
Glucose blood level
Glucose
Fasting
Dietary pattern
Diet, diabetic
Diet therapy
Diastolic blood pressure
Diabetic diet
Diabetes mellitus, type 2
Diabetes mellitus, type 1
Diabetes mellitus
Coronary-heart-disease
Clinical practice
Cardiovascular-disease
Cardiometabolic risk factors
Cardiometabolic risk factor
C reactive protein
Body weight
Body mass
Apolipoprotein b
type-2
publication bias
nutrition therapy
mexican-style diet
metabolic control
lipid profile
improves dietary
impaired glucose-tolerance
cardiovascular-disease
Entitat:Universitat Rovira i Virgili
Data d'alta del registre:2026-05-09
Volum de revista:374
Cerca el teu registre a:

Fitxers disponibles
FitxerDescripcióFormat
DocumentPrincipalDocumentPrincipalapplication/pdf


Informació

© 2011 Universitat Rovira i Virgili